Downregulation of SIRT1 also led to decreased migration and angiogenesis of ovarian cancer cells by repressing HMGB1 [5], and was associated with decreased OS in serous ovarian cancer. Here, HMGB1 is linked to ovarian serous adenocarcinoma.